ANGLE – 60p

31 January 2013 – interim results/fund raising

Interim results for the six months to 31 October revealed a loss of £0.4m although the figures are largely irrelevant given the company’s state of development.  During the period the group raised £1.1m of equity finance with another £2.3m being raised today through a placing of shares at 50p.  The proceeds of the placing will be used to strengthen the group’s cash position and support the launch of the Parsortix cancer diagnostic product for the research market.  The shares remain a BUY.

cityconfidential © 2019 | T&Cs | Privacy | Wealth Warning